Pages that link to "Q52051956"

The following pages link to Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. (Q52051956):

Displaying 100 items.

• Executive dysfunction in Parkinson's disease and timing deficits (Q21090466) (← links)
• Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome (Q21133920) (← links)
• Occupational solvent exposure and brain function: an fMRI study (Q23911060) (← links)
• Dopamine D5 receptors of rat and human brain (Q24290422) (← links)
• Alcohol and the Prefrontal Cortex (Q24608362) (← links)
• Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses (Q24619549) (← links)
• RGS4 polymorphisms associated with variability of cognitive performance in a family-based schizophrenia sample (Q24622263) (← links)
• The neuropsychopharmacology of fronto-executive function: monoaminergic modulation (Q24629562) (← links)
• Neural synchrony in schizophrenia: from networks to new treatments (Q24644168) (← links)
• Catechol-O-methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD (Q24802440) (← links)
• Catecholamines and cognition after traumatic brain injury (Q26743582) (← links)
• Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia (Q26774767) (← links)
• Neuroimaging studies of striatum in cognition part II: Parkinson's disease (Q26779306) (← links)
• Growth Hormone Secretagogue Receptor Dimers: A New Pharmacological Target(1,2,3) (Q26783258) (← links)
• Schizophrenia: a tale of two critical periods for prefrontal cortical development (Q26797157) (← links)
• The role of neuromodulators in selective attention (Q26852620) (← links)
• Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment? (Q27024858) (← links)
• From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate (Q28073785) (← links)
• Chronic cocaine disrupts mesocortical learning mechanisms (Q28081785) (← links)
• CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology (Q28137628) (← links)
• 5‐HT6 receptor antagonist SB‐271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex (Q28184669) (← links)
• The physiological role of 5-HT2A receptors in working memory (Q28211470) (← links)
• Behavioral and neural analysis of extinction (Q28215414) (← links)
• Hemispatial neglect (Q28237312) (← links)
• Intermediate phenotypes and genetic mechanisms of psychiatric disorders (Q28264588) (← links)
• Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors (Q28273285) (← links)
• The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity (Q28281024) (← links)
• Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism (Q28282922) (← links)
• Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action (Q28283418) (← links)
• Preweaning manganese exposure causes hyperactivity, disinhibition, and spatial learning and memory deficits associated with altered dopamine receptor and transporter levels (Q28394300) (← links)
• Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization (Q28396707) (← links)
• Spatial learning deficit in dopamine D(1) receptor knockout mice (Q28505043) (← links)
• Blunted brain metabolic response to ketamine in mice lacking D(1A) dopamine receptors (Q28505790) (← links)
• Dopamine D4 receptor-deficient mice display cortical hyperexcitability (Q28513386) (← links)
• Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex (Q28567004) (← links)
• Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex (Q28574634) (← links)
• Regulation of working memory by dopamine D4 receptor in rats (Q28574935) (← links)
• Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex (Q28575970) (← links)
• Cellular mechanisms for dopamine D4 receptor-induced homeostatic regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (Q28583977) (← links)
• Mice lacking dopamine D2 and D3 receptors have spatial working memory deficits (Q28586095) (← links)
• Dopamine modulates an mGluR5-mediated depolarization underlying prefrontal persistent activity (Q28586131) (← links)
• Absence of dopamine D4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear (Q28588180) (← links)
• Action sequencing is impaired in D1A-deficient mutant mice (Q28588198) (← links)
• Modification of dopamine D(1) receptor knockout phenotype in mice lacking both dopamine D(1) and D(3) receptors (Q28589976) (← links)
• Dopamine D1 receptors involved in locomotor activity and accumbens neural responses to prediction of reward associated with place (Q28590645) (← links)
• Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system (Q28594502) (← links)
• Dopaminergic therapy in aphasia (Q28655767) (← links)
• No association of COMT (Val158Met) genotype with brain structure differences between men and women (Q28730843) (← links)
• Bilinearity, rules, and prefrontal cortex (Q28757307) (← links)
• Effects of a secure attachment relationship on right brain development, affect regulation, and infant mental health (Q29037482) (← links)
• Mechanisms Underlying Differential D1 versus D2 Dopamine Receptor Regulation of Inhibition in Prefrontal Cortex (Q29395088) (← links)
• Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia (Q29614929) (← links)
• Dopamine, learning and motivation (Q29616245) (← links)
• Family and twin strategies as a head start in defining prodromes and endophenotypes for hypothetical early-interventions in schizophrenia (Q30307665) (← links)
• Linking neurogenetics and individual differences in language learning: the dopamine hypothesis. (Q30441297) (← links)
• Antenatal glucocorticoid treatment induces adaptations in adult midbrain dopamine neurons, which underpin sexually dimorphic behavioral resilience (Q30445194) (← links)
• Persistent activity in a cortical-to-subcortical circuit: bridging the temporal gap in trace eyelid conditioning (Q30459559) (← links)
• Beyond traditional approaches to understanding the functional role of neuromodulators in sensory cortices (Q30464969) (← links)
• Catechol-O-methyltransferase polymorphism modulates cognitive control in children with chromosome 22q11.2 deletion syndrome (Q30482909) (← links)
• Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition (Q30482965) (← links)
• Activation of dopamine D1 receptors blocks phencyclidine-induced neurotoxicity by enhancing N-methyl-D-aspartate receptor-mediated synaptic strength (Q30488298) (← links)
• Dynamics of action potential backpropagation in basal dendrites of prefrontal cortical pyramidal neurons (Q30489019) (← links)
• Molecular targets for treating cognitive dysfunction in schizophrenia. (Q30491310) (← links)
• Interactions between prefrontal cortex and cerebellum revealed by trace eyelid conditioning (Q30491623) (← links)
• Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission (Q30493133) (← links)
• Dissociation in human prefrontal cortex of affective influences on working memory-related activity (Q30531466) (← links)
• Neuropsychiatric dynamics: the study of mental illness using functional magnetic resonance imaging (Q30579183) (← links)
• Neurochemical brain imaging investigations of schizophrenia (Q30581142) (← links)
• Schizophrenia, the prefrontal cortex, and a mechanism of genetic susceptibility. (Q30614466) (← links)
• A model of working memory: bridging the gap between electrophysiology and human brain imaging (Q30625601) (← links)
• An adaptive coding model of neural function in prefrontal cortex (Q30665763) (← links)
• Prefrontal neurons and the genetics of schizophrenia (Q30666934) (← links)
• A theory of cognitive control, aging cognition, and neuromodulation (Q30753154) (← links)
• Distribution of protein phosphatases-1 alpha and -1 gamma 1 and the D(1) dopamine receptor in primate prefrontal cortex: Evidence for discrete populations of spines (Q30779218) (← links)
• Role of Anterior Cingulate Cortex in Instrumental Learning: Blockade of Dopamine D1 Receptors Suppresses Overt but Not Covert Learning (Q30850437) (← links)
• Identification of human dopamine D1-like receptor agonist using a cell-based functional assay (Q30863631) (← links)
• Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry (Q30975753) (← links)
• Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition. (Q31813238) (← links)
• Increased dopamine release in the human amygdala during performance of cognitive tasks (Q31929832) (← links)
• Dopamine supports sentence comprehension in Parkinson's Disease (Q32145067) (← links)
• Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization (Q32160860) (← links)
• Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI. (Q32164608) (← links)
• The computational role of dopamine D1 receptors in working memory (Q33184809) (← links)
• Differential dopaminergic modulation of executive control in healthy subjects (Q33212847) (← links)
• Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia (Q33295367) (← links)
• Mechanisms of Working Memory Impairment in Schizophrenia (Q33362926) (← links)
• Dopamine modulates persistent synaptic activity and enhances the signal-to-noise ratio in the prefrontal cortex (Q33490598) (← links)
• Frontal syndrome as a consequence of lesions in the pedunculopontine tegmental nucleus: a short theoretical review (Q33541465) (← links)
• Trans-generational effects of early life stress: the role of maternal behavior (Q33554556) (← links)
• Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys (Q33558050) (← links)
• Arc regulates experience-dependent persistent firing patterns in frontal cortex (Q33575196) (← links)
• Seeking brain biomarkers for preventive therapy in Huntington disease. (Q33606063) (← links)
• Schizophrenia and the disconnection hypothesis (Q33606287) (← links)
• Developmental changes in dopamine neurotransmission in adolescence: behavioral implications and issues in assessment (Q33625277) (← links)
• Spatial working memory alters the efficacy of input to visual cortex (Q33629865) (← links)
• Hyperdopaminergic tone erodes prefrontal long-term potential via a D2 receptor-operated protein phosphatase gate (Q33638853) (← links)
• Differential effects of COMT on gait and executive control in aging (Q33652241) (← links)
• Effects of normal aging on prefrontal area 46 in the rhesus monkey. (Q33653544) (← links)
• Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders (Q33664787) (← links)
• The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex (Q33685944) (← links)